BioVentrix, Inc. (BVXX)

BioVentrix was planning to go public, but the IPO was withdrawn on Oct 14, 2026.

Stock Price: Pending

IPO price not available yet

BioVentrix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	5.1	2.97
Research & Development	1.17	0.59
Other Operating Expenses	-6.26	0
Operating Expenses	0.01	3.56
Operating Income	-6.27	-3.56
Interest Expense (Income)	1.39	0.31
Other Expense (Income)	0.01	-0.02
Pretax Income	-7.67	-3.85
Net Income	-7.67	-3.85

Additional Metrics

Year Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-5.81	-2.72
Free Cash Flow Growth	-	-
EBITDA	-6.23	-3.5
Depreciation & Amortization	0.05	0.05
EBIT	-6.28	-3.54